Characteristics of antifungal utilization for hospitalized children in the United States

Authors

Lourdes Eguiguren, University of Nebraska Medical Center
Brian R Lee, Children's Mercy Kansas City
Jason G Newland, Washington University School of Medicine in St. Louis
Matthew P Kronman, University of Washington
Adam L Hersh, University of Utah
Jeffrey S Gerber, Children's Hospital of Philadelphia, Philadelphia, PA
Grace M Lee, Stanford University
Hayden T Schwenk, Stanford University

Journal

Antimicrobial Stewardship & Healthcare Epidemiology

Publication Date

1-1-2022

Volume

2

Issue

1

First Page

e190

Document Type

Open Access Publication

DOI

10.1017/ash.2022.338

Rights and Permissions

Eguiguren L, Lee BR, Newland JG, Kronman MP, Hersh AL, Gerber JS, Lee GM, Schwenk HT. Characteristics of antifungal utilization for hospitalized children in the United States. Antimicrob Steward Healthc Epidemiol. 2022 Dec 2;2(1):e190. doi: 10.1017/ash.2022.338 This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.

Recommended Citation

Eguiguren, Lourdes; Lee, Brian R; Newland, Jason G; Kronman, Matthew P; Hersh, Adam L; Gerber, Jeffrey S; Lee, Grace M; and Schwenk, Hayden T, "Characteristics of antifungal utilization for hospitalized children in the United States." Antimicrobial Stewardship & Healthcare Epidemiology. 2, 1. e190 (2022).
https://digitalcommons.wustl.edu/oa_4/1077

Additional Links

Supplemental material is available for this article at publisher site.